Form 4: Molina Healthcare Director Dale B. Wolf Acquires Shares Under Equity Incentive Plan

Director Dale B. Wolf acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.

Summary

• On April 1, 2025, Dale B. Wolf, a director of Molina Healthcare, Inc., acquired 168 shares of common stock.
• The acquisition was part of the company's 2019 Equity Incentive Plan and is related to Wolf's service as a director.
• The shares were granted at a price of $327.71 per share, which was the closing price of Molina Healthcare's common stock on that day.
• Following the transaction, Wolf directly owns 15,709 shares of Molina Healthcare common stock.
• The filing also includes a Limited Power of Attorney, effective March 11, 2013, authorizing Jeff D. Barlow and Codruta Boggs to execute and file Section 16(a) forms on Wolf's behalf.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and ongoing governance structure. The sentiment is neutral to slightly positive as it reflects standard corporate practices.

Positives

• The equity incentive plan aligns the interests of directors with those of shareholders.
• Director's equity award demonstrates confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the equity incentive plan suggests an ongoing commitment to aligning director compensation with company performance.

Industry Context

Equity compensation is a common practice in the healthcare industry to attract and retain qualified board members and align their interests with those of shareholders. This filing reflects standard compensation practices.

Comparison to Industry Standards

• Companies like UnitedHealth Group (UNH), Anthem (ANTM), and Cigna (CI) also utilize equity compensation for their directors.
• The value of equity grants can vary based on company size, performance, and industry benchmarks.
• A $220,000 annual equity award is within the typical range for directors of publicly traded healthcare companies of Molina's size.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning director interests with company performance.
• The equity award serves as compensation for the director's services.

Key Dates

Keywords

Molina Healthcare, Director, Equity Incentive Plan, Form 4, Beneficial Ownership, Stock Acquisition, Dale B. Wolf